355 related articles for article (PubMed ID: 8288913)
1. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Grabbe S; Bruvers S; Granstein RD
J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
[TBL] [Abstract][Full Text] [Related]
2. Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation.
Grabbe S; Bruvers S; Lindgren AM; Hosoi J; Tan KC; Granstein RD
J Leukoc Biol; 1992 Aug; 52(2):209-17. PubMed ID: 1506778
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor gene transfer to dendritic cells or epidermal cells augments their antigen-presenting function including induction of anti-tumor immunity.
Ozawa H; Ding W; Torii H; Hosoi J; Seiffert K; Campton K; Hackett NR; Topf N; Crystal RG; Granstein RD
J Invest Dermatol; 1999 Dec; 113(6):999-1005. PubMed ID: 10594743
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Grabbe S; Bruvers S; Beissert S; Granstein RD
J Leukoc Biol; 1994 Jun; 55(6):695-701. PubMed ID: 8195694
[TBL] [Abstract][Full Text] [Related]
5. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Beissert S; Hosoi J; Grabbe S; Asahina A; Granstein RD
J Immunol; 1995 Feb; 154(3):1280-6. PubMed ID: 7822797
[TBL] [Abstract][Full Text] [Related]
6. Effects of immunomodulatory cytokines on the presentation of tumor-associated antigens by epidermal Langerhans cells.
Grabbe S; Bruvers S; Granstein RD
J Invest Dermatol; 1992 Nov; 99(5):66S-68S. PubMed ID: 1431232
[TBL] [Abstract][Full Text] [Related]
7. Tumor antigen presentation by murine epidermal cells.
Grabbe S; Bruvers S; Gallo RL; Knisely TL; Nazareno R; Granstein RD
J Immunol; 1991 May; 146(10):3656-61. PubMed ID: 2026885
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of epidermal cell tumor-antigen presentation by IL-1alpha and IL-1beta.
Beissert S; Hosoi J; Stratigos A; Brissette J; Grabbe S; Schwarz T; Granstein RD
J Invest Dermatol; 1998 Oct; 111(4):609-15. PubMed ID: 9764841
[TBL] [Abstract][Full Text] [Related]
9. Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content.
Beissert S; Ullrich SE; Hosoi J; Granstein RD
J Leukoc Biol; 1995 Aug; 58(2):234-40. PubMed ID: 7643016
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tumor antigen presentation by urocanic acid.
Beissert S; Mohammad T; Torri H; Lonati A; Yan Z; Morrison H; Granstein RD
J Immunol; 1997 Jul; 159(1):92-6. PubMed ID: 9200443
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.
Heufler C; Koch F; Schuler G
J Exp Med; 1988 Feb; 167(2):700-5. PubMed ID: 3279156
[TBL] [Abstract][Full Text] [Related]
12. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells.
Udey MC; Peck RD; Pentland AP; Schreiner GF; Lefkowith JB
J Invest Dermatol; 1991 Jun; 96(6):950-8. PubMed ID: 1828477
[TBL] [Abstract][Full Text] [Related]
13. Epidermal cell presentation of tumor-associated antigens for induction of tolerance.
Tan KC; Hosoi J; Grabbe S; Asahina A; Granstein RD
J Immunol; 1994 Jul; 153(2):760-7. PubMed ID: 7912706
[TBL] [Abstract][Full Text] [Related]
14. Epidermal Langerhans cells from mice bearing a granulocyte macrophage-colony stimulating factor-producing mammary tumor display impaired accessory functions.
Xie Y; Fernandez ME; Streilein JW; Lopez DM
Anticancer Res; 1996; 16(1):9-16. PubMed ID: 8615675
[TBL] [Abstract][Full Text] [Related]
15. Aqueous humor inhibits epidermal cell antigen-presenting function.
Hosoi J; Grabbe S; Knisely TL; Granstein RD
Reg Immunol; 1993; 5(5):279-84. PubMed ID: 8148237
[TBL] [Abstract][Full Text] [Related]
16. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells.
Seiffert K; Hosoi J; Torii H; Ozawa H; Ding W; Campton K; Wagner JA; Granstein RD
J Immunol; 2002 Jun; 168(12):6128-35. PubMed ID: 12055224
[TBL] [Abstract][Full Text] [Related]
17. Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA.
Granstein RD; Ding W; Ozawa H
J Invest Dermatol; 2000 Apr; 114(4):632-6. PubMed ID: 10733665
[TBL] [Abstract][Full Text] [Related]
18. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
Sugita K; Kabashima K; Atarashi K; Shimauchi T; Kobayashi M; Tokura Y
Clin Exp Immunol; 2007 Jan; 147(1):176-83. PubMed ID: 17177977
[TBL] [Abstract][Full Text] [Related]
19. Tumor antigen presentation by dermal antigen-presenting cells.
Campton K; Ding W; Yan Z; Ozawa H; Seiffert K; Miranda E; Lonati A; Beissert S; Granstein RD
J Invest Dermatol; 2000 Jul; 115(1):57-61. PubMed ID: 10886508
[TBL] [Abstract][Full Text] [Related]
20. Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF).
Sauder DN; Noonan FP; DeFabo EC; Katz SI
J Invest Dermatol; 1983 Jun; 80(6):485-9. PubMed ID: 6222123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
